世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 ベータニコチンアミドモノヌクレオチド（NMN）の世界市場に関する洞察、2028年までの予測Global Beta-Nicotinamide Mononucleotide (NMN) Market Insights, Forecast to 2028 市場の分析と洞察。ベータ・ニコチンアミド・モノヌクレオチド（NMN）の世界市場 世界のβ-ニコチンアミドモノヌクレオチド（NMN）市場は、2021年に2億5674万米ドルと評価されています。市場規模は2028年末までに... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリー市場の分析と洞察。ベータ・ニコチンアミド・モノヌクレオチド（NMN）の世界市場世界のβ-ニコチンアミドモノヌクレオチド（NMN）市場は、2021年に2億5674万米ドルと評価されています。市場規模は2028年末までに1億7542万米ドルに達し、2022年から2028年の間に20.23%のCAGRで成長すると予測されています。 世界のβ-ニコチンアミドモノヌクレオチド（NMN）の範囲とセグメント β-ニコチンアミドモノヌクレオチド（NMN）市場は、タイプ別、用途別に区分されています。世界のベータニコチンアミドモノヌクレオチド（NMN）市場におけるプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして使用することで、優位に立つことができるようになることでしょう。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の売上、収益、予測に焦点を当てます。 企業別 ジーンハーバー ハーバルマックス ジェネックスフォーミュラ 新光和薬品 Maac10 Formulas エッフェファーマ ボンタック セルフル キングダムウェイ タイプ別セグメント コンテンツ≧98 コンテンツ ＜98 用途別セグメント ヘルスケア製品 化粧品 その他 地域別セグメント 北アメリカ 米国 カナダ アジア・パシフィック 中国 日本 韓国 インド オーストラリア 東南アジア 欧州 ドイツ フランス 英国 イタリア ロシア 中南米 メキシコ ブラジル アルゼンチン 中東・アフリカ 中東 アフリカ 目次1 STUDY COVERAGE 11.1 Beta-Nicotinamide Mononucleotide (NMN) Product Introduction 1 1.2 Market by Type 1 1.3 Market by Application 2 1.3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Application 2 1.3.2 Health Care Products 3 1.3.3 Cosmetics 4 1.4 Study Objectives 4 1.5 Years Considered 5 2 EXECUTIVE SUMMARY 6 2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Estimates and Forecasts 2017-2028 6 2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Estimates and Forecasts 2017-2028 7 2.3 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Region: 2017 VS 2022 VS 2028 8 2.4 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Sales 9 2.4.1 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Sales (2017-2022) 9 2.4.2 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Sales (2023-2028) 10 2.5 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Revenue 12 2.5.1 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Revenue (2017-2022) 12 2.5.2 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Revenue (2023-2028) 12 2.6 North America 13 2.7 Europe 14 2.8 Asia-Pacific 15 2.9 Latin America 16 2.10 Middle East and Africa 17 3 COMPETITION BY MANUFACTURERS 19 3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Manufacturers 19 3.1.1 Global Top Beta-Nicotinamide Mononucleotide (NMN) Manufacturers by Sales (2017-2022) 19 3.1.2 Global Top Beta-Nicotinamide Mononucleotide (NMN) Manufacturers Market Share by Sales (2017-2022) 20 3.1.3 Global Top 5 Companies by Beta-Nicotinamide Mononucleotide (NMN) Sales in 2021 21 3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturers 21 3.2.1 Global Top Beta-Nicotinamide Mononucleotide (NMN) Manufacturers by Revenue (2017-2022) 21 3.2.2 Global Top Beta-Nicotinamide Mononucleotide (NMN) Manufacturers Market Share by Revenue (2017-2022) 22 3.2.3 Global Top 5 Companies by Beta-Nicotinamide Mononucleotide (NMN) Revenue in 2021 23 3.3 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Price by Manufacturers 23 3.4 Analysis of Competitive Landscape 24 3.4.1 Manufacturers Market Concentration Ratio (CR5) 24 3.4.2 Global Beta-Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 24 3.4.3 Global Beta-Nicotinamide Mononucleotide (NMN) Manufacturers Geographical Distribution 25 3.5 Mergers & Acquisitions, Expansion Plans 26 4 MARKET SIZE BY TYPE 27 4.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Type 27 4.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Historical Sales by Type (2017-2022) 27 4.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Sales by Type (2023-2028) 27 4.1.3 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2017-2028) 27 4.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type 28 4.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Historical Revenue by Type (2017-2022) 28 4.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Revenue by Type (2023-2028) 29 4.2.3 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2017-2028) 29 4.3 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Type 30 4.3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Type (2017-2022) 30 4.3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Price Forecast by Type (2023-2028) 30 5 MARKET SIZE BY APPLICATION 32 5.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Application 32 5.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Historical Sales by Application (2017-2022) 32 5.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Sales by Application (2023-2028) 32 5.1.3 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028) 33 5.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application 34 5.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Historical Revenue by Application (2017-2022) 34 5.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Revenue by Application (2023-2028) 34 5.2.3 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2017-2028) 34 5.3 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Application 36 5.3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Application (2017-2022) 36 5.3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Price Forecast by Application (2023-2028) 36 6 NORTH AMERICA 37 6.1 North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 37 6.1.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 37 6.1.2 North America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 38 6.2 North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 39 6.2.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 39 6.2.2 North America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 40 6.3 North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country 42 6.3.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028) 42 6.3.2 North America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028) 43 6.3.3 U.S. 44 6.3.4 Canada 45 7 EUROPE 46 7.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 46 7.1.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 46 7.1.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 47 7.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 48 7.2.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 48 7.2.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 49 7.3 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country 51 7.3.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028) 51 7.3.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028) 52 7.3.3 Germany 54 7.3.4 France 55 7.3.5 U.K. 55 7.3.6 Italy 56 7.3.7 Russia 56 8 ASIA PACIFIC 57 8.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 57 8.1.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 57 8.1.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 58 8.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 59 8.2.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 59 8.2.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 60 8.3 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Region 62 8.3.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales by Region (2017-2028) 62 8.3.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2028) 63 8.3.3 China 65 8.3.4 Japan 66 8.3.5 Korea 67 8.3.6 India 68 8.3.7 Australia 69 8.3.8 Southeast Asia 70 9 LATIN AMERICA 71 9.1 Latin America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 71 9.1.1 Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 71 9.1.2 Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 72 9.2 Latin America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 73 9.2.1 Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 73 9.2.2 Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 74 9.3 Latin America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country 76 9.3.1 Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028) 76 9.3.2 Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028) 77 9.3.3 Mexico 79 9.3.4 Brazil 80 9.3.5 Argentina 81 10 MIDDLE EAST AND AFRICA 82 10.1 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 82 10.1.1 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 82 10.1.2 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 83 10.2 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 84 10.2.1 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 84 10.2.2 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 85 10.3 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country 87 10.3.1 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028) 87 10.3.2 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028) 88 10.3.3 Middle East 89 10.3.4 Africa 90 11 CORPORATE PROFILE 91 11.1 GeneHarbor 91 11.1.1 GeneHarbor Corporation Information 91 11.1.2 GeneHarbor Overview 91 11.1.3 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 92 11.1.4 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 92 11.1.5 GeneHarbor Recent Developments 93 11.2 Herbalmax 93 11.2.1 Herbalmax Corporation Information 93 11.2.2 Herbalmax Overview 93 11.2.3 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 94 11.2.4 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 94 11.3 Genex Formulas 95 11.3.1 Genex Formulas Corporation Information 95 11.3.2 Genex Formulas Overview 95 11.3.3 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 96 11.3.4 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 96 11.4 Shinkowa Pharmaceutical 97 11.4.1 Shinkowa Pharmaceutical Corporation Information 97 11.4.2 Shinkowa Pharmaceutical Overview 97 11.4.3 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 98 11.4.4 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 98 11.4.5 Shinkowa Pharmaceutical Recent Developments 98 11.5 Maac10 Formulas 99 11.5.1 Maac10 Formulas Corporation Information 99 11.5.2 Maac10 Formulas Overview 99 11.5.3 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 100 11.5.4 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 100 11.6 EffePharm 101 11.6.1 EffePharm Corporation Information 101 11.6.2 EffePharm Overview 101 11.6.3 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 101 11.6.4 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 102 11.7 Bontac 102 11.7.1 Bontac Corporation Information 102 11.7.2 Bontac Overview 103 11.7.3 Bontac Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 103 11.7.4 Bontac Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 104 11.7.5 Bontac Recent Developments 104 11.8 CELFULL 104 11.8.1 CELFULL Corporation Information 104 11.8.2 CELFULL Overview 105 11.8.3 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 105 11.8.4 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 105 11.9 Kingdomway 106 11.9.1 Kingdomway Corporation Information 106 11.9.2 Kingdomway Overview 106 11.9.3 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 107 11.9.4 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 108 12 VALUE CHAIN AND SALES CHANNELS ANALYSIS 109 12.1 Beta-Nicotinamide Mononucleotide (NMN) Value Chain Analysis 109 12.2 Beta-Nicotinamide Mononucleotide (NMN) Key Raw Materials 109 12.2.1 Key Raw Materials 109 12.2.2 Raw Materials Key Suppliers 109 12.3 Beta-Nicotinamide Mononucleotide (NMN) Production Mode & Process 110 12.4 Beta-Nicotinamide Mononucleotide (NMN) Sales and Marketing 110 12.4.1 Beta-Nicotinamide Mononucleotide (NMN) Sales Channels 110 12.4.2 Beta-Nicotinamide Mononucleotide (NMN) Distributors 112 12.5 Beta-Nicotinamide Mononucleotide (NMN) Customers 113 13 MARKET DRIVERS, OPPORTUNITIES, CHALLENGES AND RISKS FACTORS ANALYSIS 114 13.1 Beta-Nicotinamide Mononucleotide (NMN) Industry Trends 114 13.2 Beta-Nicotinamide Mononucleotide (NMN) Market Drivers 114 13.3 Beta-Nicotinamide Mononucleotide (NMN) Market Challenges 115 13.4 Beta-Nicotinamide Mononucleotide (NMN) Market Restraints 115 14 KEY FINDINGS IN THE GLOBAL BETA-NICOTINAMIDE MONONUCLEOTIDE (NMN) STUDY 116 15 APPENDIX 117 15.1 Research Methodology 117 15.1.1 Methodology/Research Approach 117 15.1.2 Data Source 120 15.2 Author Details 122 15.3 Disclaimer 123
SummaryMarket Analysis and Insights: Global Beta-Nicotinamide Mononucleotide (NMN) Market Table of Contents1 STUDY COVERAGE 11.1 Beta-Nicotinamide Mononucleotide (NMN) Product Introduction 1 1.2 Market by Type 1 1.3 Market by Application 2 1.3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Application 2 1.3.2 Health Care Products 3 1.3.3 Cosmetics 4 1.4 Study Objectives 4 1.5 Years Considered 5 2 EXECUTIVE SUMMARY 6 2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Estimates and Forecasts 2017-2028 6 2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Estimates and Forecasts 2017-2028 7 2.3 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Region: 2017 VS 2022 VS 2028 8 2.4 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Sales 9 2.4.1 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Sales (2017-2022) 9 2.4.2 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Sales (2023-2028) 10 2.5 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Revenue 12 2.5.1 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Revenue (2017-2022) 12 2.5.2 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Revenue (2023-2028) 12 2.6 North America 13 2.7 Europe 14 2.8 Asia-Pacific 15 2.9 Latin America 16 2.10 Middle East and Africa 17 3 COMPETITION BY MANUFACTURERS 19 3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Manufacturers 19 3.1.1 Global Top Beta-Nicotinamide Mononucleotide (NMN) Manufacturers by Sales (2017-2022) 19 3.1.2 Global Top Beta-Nicotinamide Mononucleotide (NMN) Manufacturers Market Share by Sales (2017-2022) 20 3.1.3 Global Top 5 Companies by Beta-Nicotinamide Mononucleotide (NMN) Sales in 2021 21 3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturers 21 3.2.1 Global Top Beta-Nicotinamide Mononucleotide (NMN) Manufacturers by Revenue (2017-2022) 21 3.2.2 Global Top Beta-Nicotinamide Mononucleotide (NMN) Manufacturers Market Share by Revenue (2017-2022) 22 3.2.3 Global Top 5 Companies by Beta-Nicotinamide Mononucleotide (NMN) Revenue in 2021 23 3.3 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Price by Manufacturers 23 3.4 Analysis of Competitive Landscape 24 3.4.1 Manufacturers Market Concentration Ratio (CR5) 24 3.4.2 Global Beta-Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 24 3.4.3 Global Beta-Nicotinamide Mononucleotide (NMN) Manufacturers Geographical Distribution 25 3.5 Mergers & Acquisitions, Expansion Plans 26 4 MARKET SIZE BY TYPE 27 4.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Type 27 4.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Historical Sales by Type (2017-2022) 27 4.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Sales by Type (2023-2028) 27 4.1.3 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2017-2028) 27 4.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type 28 4.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Historical Revenue by Type (2017-2022) 28 4.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Revenue by Type (2023-2028) 29 4.2.3 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2017-2028) 29 4.3 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Type 30 4.3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Type (2017-2022) 30 4.3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Price Forecast by Type (2023-2028) 30 5 MARKET SIZE BY APPLICATION 32 5.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Application 32 5.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Historical Sales by Application (2017-2022) 32 5.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Sales by Application (2023-2028) 32 5.1.3 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028) 33 5.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application 34 5.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Historical Revenue by Application (2017-2022) 34 5.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Revenue by Application (2023-2028) 34 5.2.3 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2017-2028) 34 5.3 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Application 36 5.3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Application (2017-2022) 36 5.3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Price Forecast by Application (2023-2028) 36 6 NORTH AMERICA 37 6.1 North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 37 6.1.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 37 6.1.2 North America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 38 6.2 North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 39 6.2.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 39 6.2.2 North America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 40 6.3 North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country 42 6.3.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028) 42 6.3.2 North America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028) 43 6.3.3 U.S. 44 6.3.4 Canada 45 7 EUROPE 46 7.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 46 7.1.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 46 7.1.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 47 7.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 48 7.2.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 48 7.2.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 49 7.3 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country 51 7.3.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028) 51 7.3.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028) 52 7.3.3 Germany 54 7.3.4 France 55 7.3.5 U.K. 55 7.3.6 Italy 56 7.3.7 Russia 56 8 ASIA PACIFIC 57 8.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 57 8.1.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 57 8.1.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 58 8.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 59 8.2.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 59 8.2.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 60 8.3 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Region 62 8.3.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales by Region (2017-2028) 62 8.3.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2028) 63 8.3.3 China 65 8.3.4 Japan 66 8.3.5 Korea 67 8.3.6 India 68 8.3.7 Australia 69 8.3.8 Southeast Asia 70 9 LATIN AMERICA 71 9.1 Latin America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 71 9.1.1 Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 71 9.1.2 Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 72 9.2 Latin America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 73 9.2.1 Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 73 9.2.2 Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 74 9.3 Latin America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country 76 9.3.1 Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028) 76 9.3.2 Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028) 77 9.3.3 Mexico 79 9.3.4 Brazil 80 9.3.5 Argentina 81 10 MIDDLE EAST AND AFRICA 82 10.1 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 82 10.1.1 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 82 10.1.2 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 83 10.2 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 84 10.2.1 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 84 10.2.2 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 85 10.3 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country 87 10.3.1 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028) 87 10.3.2 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028) 88 10.3.3 Middle East 89 10.3.4 Africa 90 11 CORPORATE PROFILE 91 11.1 GeneHarbor 91 11.1.1 GeneHarbor Corporation Information 91 11.1.2 GeneHarbor Overview 91 11.1.3 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 92 11.1.4 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 92 11.1.5 GeneHarbor Recent Developments 93 11.2 Herbalmax 93 11.2.1 Herbalmax Corporation Information 93 11.2.2 Herbalmax Overview 93 11.2.3 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 94 11.2.4 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 94 11.3 Genex Formulas 95 11.3.1 Genex Formulas Corporation Information 95 11.3.2 Genex Formulas Overview 95 11.3.3 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 96 11.3.4 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 96 11.4 Shinkowa Pharmaceutical 97 11.4.1 Shinkowa Pharmaceutical Corporation Information 97 11.4.2 Shinkowa Pharmaceutical Overview 97 11.4.3 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 98 11.4.4 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 98 11.4.5 Shinkowa Pharmaceutical Recent Developments 98 11.5 Maac10 Formulas 99 11.5.1 Maac10 Formulas Corporation Information 99 11.5.2 Maac10 Formulas Overview 99 11.5.3 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 100 11.5.4 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 100 11.6 EffePharm 101 11.6.1 EffePharm Corporation Information 101 11.6.2 EffePharm Overview 101 11.6.3 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 101 11.6.4 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 102 11.7 Bontac 102 11.7.1 Bontac Corporation Information 102 11.7.2 Bontac Overview 103 11.7.3 Bontac Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 103 11.7.4 Bontac Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 104 11.7.5 Bontac Recent Developments 104 11.8 CELFULL 104 11.8.1 CELFULL Corporation Information 104 11.8.2 CELFULL Overview 105 11.8.3 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 105 11.8.4 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 105 11.9 Kingdomway 106 11.9.1 Kingdomway Corporation Information 106 11.9.2 Kingdomway Overview 106 11.9.3 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 107 11.9.4 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 108 12 VALUE CHAIN AND SALES CHANNELS ANALYSIS 109 12.1 Beta-Nicotinamide Mononucleotide (NMN) Value Chain Analysis 109 12.2 Beta-Nicotinamide Mononucleotide (NMN) Key Raw Materials 109 12.2.1 Key Raw Materials 109 12.2.2 Raw Materials Key Suppliers 109 12.3 Beta-Nicotinamide Mononucleotide (NMN) Production Mode & Process 110 12.4 Beta-Nicotinamide Mononucleotide (NMN) Sales and Marketing 110 12.4.1 Beta-Nicotinamide Mononucleotide (NMN) Sales Channels 110 12.4.2 Beta-Nicotinamide Mononucleotide (NMN) Distributors 112 12.5 Beta-Nicotinamide Mononucleotide (NMN) Customers 113 13 MARKET DRIVERS, OPPORTUNITIES, CHALLENGES AND RISKS FACTORS ANALYSIS 114 13.1 Beta-Nicotinamide Mononucleotide (NMN) Industry Trends 114 13.2 Beta-Nicotinamide Mononucleotide (NMN) Market Drivers 114 13.3 Beta-Nicotinamide Mononucleotide (NMN) Market Challenges 115 13.4 Beta-Nicotinamide Mononucleotide (NMN) Market Restraints 115 14 KEY FINDINGS IN THE GLOBAL BETA-NICOTINAMIDE MONONUCLEOTIDE (NMN) STUDY 116 15 APPENDIX 117 15.1 Research Methodology 117 15.1.1 Methodology/Research Approach 117 15.1.2 Data Source 120 15.2 Author Details 122 15.3 Disclaimer 123
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
